The 21 Cfr Part 11 Guidelines For Pharmaceuticals are a set of regulations issued by the United States Food and Drug Administration (FDA) which establishes the criteria for providing secure electronic records and signatures that are legally binding. These guidelines ensure that pharmaceutical products are held to high standards of security, quality and reliability. By adhering to the 21 CFR Part 11 guidelines, organizations can guarantee that their pharmaceutical products are compliant with FDA requirements.